Inhaled Surfactant Therapy in Newborns in Artificial Lung Ventilation
Objective: to evaluate the efficiency of inhaled surfactant therapy in neonatal infants with respiratory failure.Subjects and methods. The trial enrolled 13 premature neonatal infants; their mean gestational age was 31.8±2.8 weeks and the birth weight was 1825±600.9 g. They had a oneminute Apgar sco...
Saved in:
| Main Authors: | S. A. Perepelitsa, A. A. Luchina |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia
2014-10-01
|
| Series: | Общая реаниматология |
| Subjects: | |
| Online Access: | https://www.reanimatology.com/rmt/article/view/1420 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Does inhaled salbutamol before surfactant therapy have any beneficial effect?
by: H Tolga Çelik, et al.
Published: (2018-12-01) -
C-Reactive Protein and Procalcitonin Diagnostic Value in Congenital Infection in Newborns with Extremely Low and Very Low Birth Weight
by: O. V. Mikhaylova, et al.
Published: (2015-11-01) -
Replacement Therapy with the Surfactant Alveofact for Neonatal Respiratory Distress Syndrome: A Pilot Study
by: S. A. Perepelitsa
Published: (2014-08-01) -
Effect of different CPAP levels on ultrasound-assessed lung aeration and gas exchange in neonates
by: Victor Sartorius, et al.
Published: (2024-10-01) -
Lung Surfactant Deficiency in Severe Respiratory Failure: A Potential Biomarker for Clinical Assessment
by: Peter Schousboe, et al.
Published: (2025-03-01)